Copy to clipboard 
restor3d completed the previously-announced acquisition of Conformis.
Conformis’ vision for personalized implants never quite came to fruition, as operational roadblocks overlapped with market disruption from the pandemic. A patient-specific instrument partnership with Stryker didn’t make much of an impression, and Conformis struggled to both sell and implement its Platinum Services model. The acquisition by restor3d gives Conformis’ compelling intellectual property another chance to make an impact in orthopedics.
restor3d manufactures personalized orthopedic devices from patient-specific to patient-matched, as well as associated ancillary products. Conformis designs and manufactures customized knee and hip replacements specifically for each individual patient. With restor3d’s existing expertise in 3D printing of osseointegrative biomedical materials, biomechanics modeling, artificial-intelligence-based planning and design automation tools, the addition of Conformis can help to propel a scalable future of personalized device solutions.
“We are extremely excited to complete this important transaction and look forward to leveraging our combined portfolio to deliver personalized orthopedic solutions for the whole human body,” said J. Kurt Jacobus, CEO of restor3d. “With the addition of Conformis to the organization, we see tremendous opportunity to deliver clinically differentiated and cost-effective solutions across the orthopedic landscape, including shoulder, foot & ankle, spine, and large joints such as knees and hips. We have mapped out a product roadmap that will deepen and extend our offerings across the body, providing surgeons and patients with the personalized device solutions they deserve.”
Source: restor3d, Inc.
restor3d completed the previously-announced acquisition of Conformis.
Conformis’ vision for personalized implants never quite came to fruition, as operational roadblocks overlapped with market disruption from the pandemic. A patient-specific instrument partnership with Stryker didn’t make much of an impression, and Conformis struggled to...
restor3d completed the previously-announced acquisition of Conformis.
Conformis’ vision for personalized implants never quite came to fruition, as operational roadblocks overlapped with market disruption from the pandemic. A patient-specific instrument partnership with Stryker didn’t make much of an impression, and Conformis struggled to both sell and implement its Platinum Services model. The acquisition by restor3d gives Conformis’ compelling intellectual property another chance to make an impact in orthopedics.
restor3d manufactures personalized orthopedic devices from patient-specific to patient-matched, as well as associated ancillary products. Conformis designs and manufactures customized knee and hip replacements specifically for each individual patient. With restor3d’s existing expertise in 3D printing of osseointegrative biomedical materials, biomechanics modeling, artificial-intelligence-based planning and design automation tools, the addition of Conformis can help to propel a scalable future of personalized device solutions.
“We are extremely excited to complete this important transaction and look forward to leveraging our combined portfolio to deliver personalized orthopedic solutions for the whole human body,” said J. Kurt Jacobus, CEO of restor3d. “With the addition of Conformis to the organization, we see tremendous opportunity to deliver clinically differentiated and cost-effective solutions across the orthopedic landscape, including shoulder, foot & ankle, spine, and large joints such as knees and hips. We have mapped out a product roadmap that will deepen and extend our offerings across the body, providing surgeons and patients with the personalized device solutions they deserve.”
Source: restor3d, Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
